Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Solid Biosciences stock | $2

Learn how to easily invest in Solid Biosciences stock.

Solid Biosciences Inc is a drug manufacturers-specialty & generic business based in the US. Solid Biosciences shares (SLDB) are listed on the NASDAQ and all prices are listed in US Dollars. Solid Biosciences employs 70 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Solid Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SLDB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Solid Biosciences stock price (NASDAQ: SLDB)

Use our graph to track the performance of SLDB stocks over time.

Solid Biosciences shares at a glance

Information last updated 2021-10-25.
Latest market close$2.00
52-week range$1.96 - $11.58
50-day moving average $2.49
200-day moving average $3.40
Wall St. target price$9.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.00

Buy Solid Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Solid Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Solid Biosciences price performance over time

Historical closes compared with the close of $2 from 2021-10-25

1 week (2021-10-20) -7.41%
1 month (2021-09-27) -23.08%
3 months (2021-07-27) -27.27%
6 months (2021-04-27) -61.76%
1 year (2020-10-26) -41.86%
2 years (2019-10-25) -83.36%
3 years (2018-10-26) 33.11
5 years (2016-10-23) N/A

Solid Biosciences financials

Revenue TTM $6.9 million
Gross profit TTM $0
Return on assets TTM -30.17%
Return on equity TTM -56.13%
Profit margin 0%
Book value $2.16
Market capitalisation $223.9 million

TTM: trailing 12 months

Shorting Solid Biosciences shares

There are currently 7.0 million Solid Biosciences shares held short by investors – that's known as Solid Biosciences's "short interest". This figure is 9.7% up from 6.4 million last month.

There are a few different ways that this level of interest in shorting Solid Biosciences shares can be evaluated.

Solid Biosciences's "short interest ratio" (SIR)

Solid Biosciences's "short interest ratio" (SIR) is the quantity of Solid Biosciences shares currently shorted divided by the average quantity of Solid Biosciences shares traded daily (recently around 1.6 million). Solid Biosciences's SIR currently stands at 4.4. In other words for every 100,000 Solid Biosciences shares traded daily on the market, roughly 4400 shares are currently held short.

However Solid Biosciences's short interest can also be evaluated against the total number of Solid Biosciences shares, or, against the total number of tradable Solid Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Solid Biosciences's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Solid Biosciences shares in existence, roughly 60 shares are currently held short) or 0.1185% of the tradable shares (for every 100,000 tradable Solid Biosciences shares, roughly 119 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Solid Biosciences.

Find out more about how you can short Solid Biosciences stock.

Solid Biosciences share dividends

We're not expecting Solid Biosciences to pay a dividend over the next 12 months.

Solid Biosciences share price volatility

Over the last 12 months, Solid Biosciences's shares have ranged in value from as little as $1.96 up to $11.58. A popular way to gauge a stock's volatility is its "beta".

SLDB.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Solid Biosciences's is 0.998. This would suggest that Solid Biosciences's shares are less volatile than average (for this exchange).

Solid Biosciences overview

Solid Biosciences Inc. , a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy.

Frequently asked questions

What percentage of Solid Biosciences is owned by insiders or institutions?
Currently 12.881% of Solid Biosciences shares are held by insiders and 73.7% by institutions.
How many people work for Solid Biosciences?
Latest data suggests 70 work at Solid Biosciences.
When does the fiscal year end for Solid Biosciences?
Solid Biosciences's fiscal year ends in December.
Where is Solid Biosciences based?
Solid Biosciences's address is: 141 Portland Street, Cambridge, MA, United States, 02139
What is Solid Biosciences's ISIN number?
Solid Biosciences's international securities identification number is: US83422E1055
What is Solid Biosciences's CUSIP number?
Solid Biosciences's Committee on Uniform Securities Identification Procedures number is: 83422E105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site